Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

BRIEF-Nuvo Pharmaceuticals - U.S. Court Denied Motion For Summary Judgment Filed By Dr. Reddy's Laboratories

Published 2019-11-11, 08:11 a/m
Updated 2019-11-11, 11:47 a/m
© Reuters.  BRIEF-Nuvo Pharmaceuticals - U.S. Court Denied Motion For Summary Judgment Filed By Dr. Reddy's Laboratories

Nov 11 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :

* NUVO PHARMACEUTICALS INC - UNITED STATES COURT DENIED A MOTION FOR SUMMARY JUDGMENT FILED BY DR. REDDY'S LABORATORIES

* NUVO PHARMACEUTICALS INC - PATENT INFRINGEMENT LITIGATION AGAINST DRL WILL CONTINUE

* NUVO PHARMACEUTICALS INC - PARTIES MUTUALLY AGREED ON A PRE-TRIAL LITIGATION SCHEDULE WITH COURT THROUGH TO APRIL 2021

* NUVO PHARMACEUTICALS - WHILE LITIGATION IS PENDING, DRL MAY STILL LAUNCH GENERIC VERSION OF VIMOVO "AT RISK" UPON APPROVAL BY U.S. FDA

* NUVO PHARMA - IF "AT RISK" LAUNCH OCCURS, NUVO IRELAND AND U.S. PARTNER CAN CONTINUE TO ENFORCE '996 & '920 PATENTS AGAINST DRL & SEEK DAMAGES

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.